Mutagen sensitivity as measured by induced chromatid breakage as a marker of cancer risk

Methods in Molecular Biology

Volumn 1105, Issue , 2014, Pages 183-192

  Wu, Xifeng ^a   Zheng, Yun Ling ^a   Hsu, T C ^a  

^a NONE

Author keywords

Benzopyrene; Bleomycin; Cancer susceptibility; Chromatid breaks; Mutagen sensitivity; Nitroquinoline; irradiation

Indexed keywords

MUTAGENIC AGENT; 4 NITROQUINOLINE 1 OXIDE; 4 NITROQUINOLONE 1 OXIDE; 4-NITROQUINOLONE-1-OXIDE; BENZO[A]PYRENE 7,8 DIHYDRODIOL 9,10 OXIDE; BLEOMYCIN; QUINOLONE DERIVATIVE;

ARTICLE; CANCER RISK; CHROMOSOME BREAKAGE; CONTROLLED STUDY; DICENTRIC CHROMOSOME; DNA ADDUCT; DNA CROSS LINKING; DNA REPAIR; FUNCTIONAL ASSESSMENT; HEREDITY; HUMAN; HUMAN CELL; IN VITRO STUDY; KARYOTYPE; LYMPHOCYTE CULTURE; METAPHASE CHROMOSOME; MUTAGEN SENSITIVITY; MUTAGEN TESTING; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RADIOSENSITIVITY; RISK ASSESSMENT; SISTER CHROMATID; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CHROMATID; DOUBLE STRANDED DNA BREAK; DRUG EFFECT; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; LYMPHOCYTE; NEOPLASM; PHYSIOLOGY; RADIATION EXPOSURE; RADIATION INJURY; RISK;

4-NITROQUINOLINE-1-OXIDE; 7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; BLEOMYCIN; CELLS, CULTURED; CHROMATIDS; DNA BREAKS, DOUBLE-STRANDED; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOCYTES; MUTAGENS; NEOPLASMS; QUINOLONES; RADIATION INJURIES; RISK;

EID: 84908548189     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-739-6_15     Document Type: Article

References (33)

1. Hsu TC (1983) Genetic instability in the human population: a working hypothesis. Hereditas 98:1–9
2. Hsu TC, Johnston DA, Cherry LM et al (1989) Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer 43: 403–409
3. Hsu TC, Spitz MR, Schantz SP (1991) Mutagen sensitivity: a biologic marker of cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1:83–89
4. Wu X, Gu J, Spitz MR (2007) Mutagen sensitivity: a genetic predisposition factor for cancer. Cancer Res 67:3493–3495
5. Spitz MR, Fueger JJ, Beddingfi eld NA et al (1989) Chromosome sensitivity to bleomycininduced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res 49:4626–4628
6. Schantz SP, Hsu TC, Ainslie N, Moser RP (1989) Young adults with head and neck cancer express increased susceptibility to mutageninduced chromosome damage. JAMA 262: 3313–3315
7. Spitz MR, Fueger JJ, Halabi S, Schantz SP, Sample D, Hsu TC (1993) Mutagen sensitivity in upper aerodigestive tract cancer: a case–control analysis. Cancer Epidemiol Biomarkers Prev 2:329–333
8. Cloos J, Steen I, Joenje H et al (1993) Association between bleomycin genotoxicity and non-constitutional risk factors for head and neck cancer. Cancer Lett 74:161–165
9. Cloos J, Spitz MR, Schantz SP et al (1996) Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst 88: 530–535
10. Wu X, Gu J, Hong WK et al (1998) Benzo[ a ] pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst 90:1393–1399
11. Spitz MR, Hsu TC, Wu XF, Fueger JJ, Amos CI, Roth JA (1995) Mutagen sensitivity as a biologic marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev 4:99–103
12. Strom SS, Wu X, Sigurdson AJ et al (1995) Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans. J Natl Cancer Inst 18:29–33
13. Wu X, Delclos GL, Annegers FJ et al (1995) A case–control study of wood-dust exposure, mutagen sensitivity, and lung-cancer risk. Cancer Epidemiol Biomarkers Prev 4:583–588
14. Wu X, Gu J, Amos CI, Jiang H, Hong WK, Spitz MR (1998) A parallel study of in vitro sensitivity to benzo[ a ]pyrene diol epoxide and bleomycin in lung cancer cases and controls. Cancer 83:1118–1127
15. Wu X, Gu J, Patt Y et al (1998) Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 7:567–570
16. Spitz MR, Lippman SM, Jiang H et al (1998) Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract. J Natl Cancer Inst 90: 243–245
17. Hsu TC, Feun L, Trizna Z et al (1993) Differential sensitivity among three human subpopulations in response to 4- nitroquinoline- 1-oxide and to bleomycin. Int J Oncol 3: 827–830
18. Bondy ML, Kyritis AP, Gu J et al (1996) Mutagen sensitivity and risk of glioma: a case– control analysis. Cancer Res 56:1484–1486
19. Buchholz TA, Wu XF (2001) Radiationinduced chromatid breaks as a predictor of breast cancer risk. Int J Radiat Oncol Biol Phys 49:533–537
20. Wu X, Hsu TC, Spitz MR (1996) Mutagen sensitivity exhibits a dose–response relationship in case–control studies. Cancer Epidemiol Biomarkers Prev 5:577–578
21. Wang L-E, Xiong P, Strom SS et al (2005) In vitro sensitivity to ultraviolet B light and skin cancer risk: a case–control analysis. J Natl Cancer Inst 97:1822–1831
22. Xu YJ, Kim EY, Demple B (1998) Excision of C-4′-oxidized deoxyribose lesions from double- stranded DNA by human apurinic/ apyrimidinic endonuclease (Ape1 protein) and DNA polymerase beta. J Biol Chem 273: 28837–28844
23. Dar ME, Winters TA, Jorgensen TJ (1997) Identifi cation of defective illegitimate recombinational repair of oxidatively-induced DNA double-strand breaks in ataxia-telangiectasia cells. Mutat Res 384:169–179
24. Thompson LH (1998) Nucleotide excision repair: its relation to human disease. In: Nickoloff JA, Hoekstra MF (eds) DNA Damage and Repair, Volume 2: DNA Repair in Higher Eukaryotes. Humana, Totowa, NJ, pp 335–393
25. Arce GT, Allen JW, Doerr CL et al (1987) Relationships between benzo(a)pyrene-DNA adducts levels and genotoxic effects in mammalian cells. Cancer Res 47:3388–3395
26. Wolterbeek AP, Roggeband R, Steenwinkel MJ, Rutten AA, Baan RA (1993) Formation and repair of benzo[ a ]pyrene-DNA adducts in cultured hamster tracheal epithelium determined by 32 P-postlabeling analysis and unscheduled DNA synthesis. Carcinogenesis 14: 463–467
27. Shou M, Harvey RG, Penning TM (1993) Reactivity of benzo[ a ]pyrene-7,8-dione with DNA. Evidence for the formation of deoxyguanosine adducts. Carcinogenesis 14:475–482
28. Tang MS, Pierce JR, Doisy RP, Nazimiec ME, Macleod MC (1992) Differences and similarities in the repair of two benzo[a]pyrene diol epoxide isomers induced DNA adducts by uvr A, uvr B, and uvr C gene products. Biochemistry 31:8429–8436
29. Xiong P, Bondy ML, Li D et al (2001) Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S -transferase polymorphisms: a case–control study. Cancer Res 61:8465–8469
30. Kosti O, Byrne C, Meeker KL et al (2010) Mutagen sensitivity, tobacco smoking and breast cancer risk: a case–control study. Carcinogenesis 31:654–659
31. Jin C, Jin Y, Wennerberg J, Rosenquist B, Mertens F (2008) Increased sensitivity to bleomycin in upper aerodigestive tract mucosa of head and neck squamous cell carcinoma patients. Mutat Res 652:30–37
32. Chatham Workshop Conference (1971) Chatham workshop conference on karyological monitoring of normal cell populations. Inter national association of biological standardization. Cape Cod, MA
33. Hsu TC, Wu X, Trizna Z (1996) Mutagen sensitivity in humans: a comparison between two nomenclature systems for recording chromatid breaks. Cancer Genet Cytogenet 87: 127–132